Trends in gabapentin and baclofen exposures reported to U.S. poison centers

  title={Trends in gabapentin and baclofen exposures reported to U.S. poison centers},
  author={Kimberly Reynolds and Robert E. Kaufman and Amanda S. Korenoski and Laura A. Fennimore and Joshua Shulman and Michael J Lynch},
  journal={Clinical Toxicology},
  pages={763 - 772}
Abstract Context: Prescriptions for nonopioid pharmacological therapies such as gabapentin and baclofen have been increasing. While gabapentin and baclofen are less likely than opioids to result in fatal overdose, they are each associated with dependence, misuse and adverse effects. Objective: The objective of this study is to evaluate and describe trends in adult exposures to gabapentin and baclofen reported to U.S. Poison Centers. Methods: This was a retrospective review of data collected by… 

Assessment of gabapentin misuse using prescription drug monitoring program data

Gabapentin dispensing patterns were described and there was no evidence of misuse using PDMP data based on the Lorenz-1 value, yet supratherapeutic dosing of gabapentin was observed and was associated with OUD.

Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths — 23 States and the District of Columbia, 2019–2020

To assess quarterly trends in gabapentin-involved overdose deaths of unintentional or undetermined intent during 2019–2020, CDC analyzed data from the State Unintentional Drug Overdose Reporting System (SUDORS) in 23 states and the District of Columbia.

Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup.

The EXTRIP workgroup suggests against performing ECTR in addition to standard care rather than standard care alone (weak recommendation, very low quality of evidence) for gabapentinoid poisoning in patients with normal kidney function.

Current Evidence on Abuse and Misuse of Gabapentinoids

Some evidence supports the notion that patients with opioid use disorders may be at an increased risk of abusing gabapentinoids and that individuals with a history of psychiatric disorders or substance use disorder seem to be at high risk.

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”

A targeted narrative review of the benefits and risks of gabapentinoids in the context of general medical, specialty pain management, and addiction medicine practice to ameliorate current confusion regarding the class of drugs among clinicians, pharmacists, and public health workers alike.

Coprescription of Opioids With Other Medications and Risk of Opioid Overdose

Baclofen, lorazepam, and gabapentin, among other non-opioid medications, were associated with opioid overdose and similar patterns were observed in non-cancer patients and individuals who used only oxycodone.

Classics in Chemical Neuroscience: Baclofen.

The >60 year legacy of baclofen is captured by walking through the history, pharmacology, synthesis, drug metabolism, routes of administration and societal impact of this Classic in chemical neuroscience.

Managing the misuse potential and risk of psychological harm from gabapentinoids in primary care in New Zealand.

The current international literature is summarized and three main risk factors are identified that can be used for screening purposes when considering prescribing a gabapentinoid, to identify patients that may be at greater risk of harm.

Oral baclofen toxicity in older patients with chronic kidney disease

1. Removal of drugs for Alzheimer's disease from the list of reimbursable drugs in France: analysis of change in drug use, disease management and cognition using the National Alzheimer Data Bank (BNA).



Characterization Of Gabapentin Overdose Using A Poison Center Case Series

In this cases series, gabapentin exposures caused no or minimal toxicity, and patients remained asymptomatic with reported effects of drowsiness and ataxia.

Baclofen overdose: drug experimentation in a group of adolescents.

Baclofen overdose may result in coma, apnea, autonomic disturbances, cardiac conduction abnormalities, and seizures, and Persistent symptoms were noted in some patients, despite nondetectable bacl ofen levels.

Gabapentin misuse, abuse and diversion: a systematic review.

Empirical and case report evidence suggests that the anti-epileptic and analgesic medication gabapentin is being misused internationally, with substance abuse populations at special risk for misuse/abuse.

Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.

The aim of this study was to determine the prevalence, frequency and sources of misuse of the GABA analogues (baclofen, gabapentin and pregabalin) in the UK, and to benchmark against existing national data provided by the 2011/2012 Crime Survey for England and Wales.

Gabapentin use in a managed medicaid population.

Almost all patients in this sample from the Medicaid managed population received gabapentin for off-label indications, and evidence from clinical trials does not support the use of gabAPentin for many of the conditions treated with gABapentin in this study.

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study

Among patients receiving prescription opioids, concomitant treatment with gabapentin was associated with a substantial increase in the risk of accidental opioid-related mortality, and doctors should consider carefully whether to adjust opioid dose accordingly.

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

State-by-state efforts to enhance pharmacovigilance are reported and a re-evaluation of the schedule status of gabapentin at the federal level, and design and implementation of a national pharmacov Vigilance program are called for.

Gabapentinoid Abuse in Order to Potentiate the Effect of Methadone: A Survey among Substance Misusers

Background/Aims: There is emerging evidence of gabapentin and pregabalin (gabapentinoid) abuse, particularly in the substance misuse population, and some suggestion of gabapentinoids being abused

Baclofen and Alcohol‐Dependent Patients: A Real Risk of Severe Self‐Poisoning

Baclofen, prescribed in high doses, may lead to severe poisoning, particularly in patients with psychiatric illnesses, and authorities should put forward a new policy for prescribing the drug as a treatment for alcohol dependence.